BAM
RLAY icon

Blueshift Asset Management’s Relay Therapeutics RLAY Stock Holding History

Blueshift Asset Management’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-26,814
Closed -$227K – 628
2025
Q4 		$227K Buy
+26,814
New +$191K 0.07% 391
2021
Q4 		– Sell
-9,836
Closed -$310K – 1169
2021
Q3 		$310K Buy
9,836
+1,716
+21% +$57.8K 0.02% 798
2021
Q2 		$297K Buy
+8,120
New +$268K 0.02% 735

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Blueshift Asset Management's RLAY Position: Q1 2026 in Review

Blueshift Asset Management sold out of Relay Therapeutics (RLAY) in Q1 2026, closing a stake of 26,814 shares — an estimated $227K sold.

Blueshift Asset Management first reported a position in RLAY in Q2 2021 and held it in 3 quarters. The position peaked at $310K in Q3 2021. 244 funds tracked by Wall St. Rank hold RLAY as of Q1 2026.

  • Blueshift Asset Management reported no remaining Relay Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Blueshift Asset Management sold 26,814 Relay Therapeutics shares in Q1 2026, an estimated $227K.
  • Blueshift Asset Management first reported a position in Relay Therapeutics in Q2 2021 and held it in 3 quarters.
  • Blueshift Asset Management's Relay Therapeutics position peaked at $310K in Q3 2021.
  • 244 funds tracked by Wall St. Rank held Relay Therapeutics as of Q1 2026.

Based on Blueshift Asset Management's 13F filing for Q1 2026, filed 14 May 2026.